Cencora rises after $1.1 billion EyeSouth retina deal
23/03/2026 11:42
** Shares of drug distributor Cencora COR.N rise 1.8% to $332.68 premarket ** Co says it will buy EyeSouth Partners’ retina business in a deal valued at $1.1 billion, expanding its eye-care specialist network ** Deal adds EyeSouth’s retina physicians to Cencora’s Retina Consultants of America, which manages eye doctors and clinics, co says ** Says the acquisition is expected to slightly lift adjusted EPS in the first year after closing, even after financing costs ** Co reaffirmed its fiscal 2026 forecast, noting it does not include the impact of the deal ** Transaction is subject to regulatory approvals and customary closing conditions - COR ** Shares up about 50% in 2025 (Reporting by Sahil Pandey in Bengaluru) ((Sahil.Pandey@thomsonreuters.com))